Transplantation of chemically-induced liver progenitor cells ameliorates hepatic fibrosis in mice with diet-induced nonalcoholic steatohepatitis

Regenerative Therapy - Tập 21 - Trang 574-583 - 2022
Shunsuke Murakami1, Akihiko Soyama1, Daisuke Miyamoto1, Takanobu Hara1, Kunihito Matsuguma1, Hajime Imamura1, Hajime Matsushima1, Takayuki Tanaka1, Yasuhiro Maruya1, Tomohiko Adachi1, Satoshi Miuma2, Masaaki Hidaka1, Kengo Kanetaka1, Takahiro Ochiya3, Susumu Eguchi1
1Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
2Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
3Department of Molecular and Cellular Medicine, Tokyo Medical University, Tokyo, Japan

Tài liệu tham khảo

Nicolas, 2016, Cell therapy in chronic liver disease, Curr Opin Gastroenterol, 32, 189 Horslen, 2003, Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder, Pediatrics, 111, 1262, 10.1542/peds.111.6.1262 Barone, 2004, Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats, Virchows Arch, 444, 554, 10.1007/s00428-004-0998-0 Enosawa, 2014, Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes, Liver Transplant, 20, 391, 10.1002/lt.23800 Si-Tayeb, 2010, Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells, Hepatology, 51, 297, 10.1002/hep.23354 Kido, 2015, CPM is a useful cell surface marker to isolate expandable Bi-potential liver progenitor cells derived from human iPS cells, Stem Cell Rep, 5, 508, 10.1016/j.stemcr.2015.08.008 Katsuda, 2017, Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity, Cell Stem Cell, 20, 41, 10.1016/j.stem.2016.10.007 Katsuda, 2019, Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes, Elife, 8, 10.7554/eLife.47313 Katsuda, 2017, Biological and clinical insights offered by chemically induced liver progenitors (CLiPs), Stem Cell Invest, 4, 68, 10.21037/sci.2017.08.04 Rezvani, 2016, Assessing the therapeutic potential of lab-made hepatocytes, Hepatology, 64, 287, 10.1002/hep.28569 Burra, 2019, The ILTS consensus conference on NAFLD/NASH and liver transplantation: setting the stage, Transplantation, 103, 19, 10.1097/TP.0000000000002507 Younossi, 2018, Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation, Liver Transplant, 24, 166, 10.1002/lt.25003 Sakai, 2018, Controlled cell morphology and liver-specific function of engineered primary hepatocytes by fibroblast layer cell densities, J Biosci Bioeng, 126, 249, 10.1016/j.jbiosc.2018.02.006 Katsuda, 2018, Generation of chemically induced liver progenitors (CLiPs) from rat adult hepatocytes, Bio Protoc, 8, e2689, 10.21769/BioProtoc.2689 Katsuda, 2019, Chemically induced liver progenitors (CLiPs): a novel cell source for hepatocytes and biliary epithelial cells, Methods Mol Biol, 1905, 117, 10.1007/978-1-4939-8961-4_11 Huang, 2019, Development of bifunctional three-dimensional cysts from chemically induced liver progenitors, Stem Cell Int, 2019 Huang, 2021, Bioengineering of a CLiP-derived tubular biliary-duct-like structure for bile transport in vitro, Biotechnol Bioeng, 118, 2572, 10.1002/bit.27773 Miyoshi, 2022, Successful induction of human chemically induced liver progenitors with small molecules from damaged liver, J Gastroenterol, 57, 441, 10.1007/s00535-022-01869-5 Azuma, 2021, IL-19 contributes to the development of nonalcoholic steatohepatitis by altering lipid metabolism, Cells, 10 Huang, 2021, Chemical conversion of aged hepatocytes into bipotent liver progenitor cells, Hepatol Res, 51, 323, 10.1111/hepr.13609 Loomba, 2014, Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis, Clin Gastroenterol Hepatol, 12, 1731, 10.1016/j.cgh.2014.03.026 Sanyal, 2011, Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatology, 54, 344, 10.1002/hep.24376 Hoofnagle, 2013, Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis, Aliment Pharmacol Ther, 38, 134, 10.1111/apt.12352 Chen, 2019, Combatting fibrosis: exosome-based therapies in the regression of liver fibrosis, Hepatol Commun, 3, 180, 10.1002/hep4.1290 Meng, 2012, Epigenetic regulation of miR-34a expression in alcoholic liver injury, Am J Pathol, 181, 804, 10.1016/j.ajpath.2012.06.010 Hyung, 2020, Exosomes derived from chemically induced human hepatic progenitors inhibit oxidative stress induced cell death, Biotechnol Bioeng, 117, 2658, 10.1002/bit.27447 Rong, 2019, Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/beta-catenin pathway, Stem Cell Res Ther, 10, 98, 10.1186/s13287-019-1204-2 Bosma, 1983, A severe combined immunodeficiency mutation in the mouse, Nature, 301, 527, 10.1038/301527a0